LOS ANGELES, CA / ACCESSWIRE / March 23, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against USANA Health Sciences, Inc. ("USANA" or the "Company") (NYSE: USNA). Investors, who purchased or otherwise acquired shares between March 14, 2014 and February 7, 2017, inclusive (the "Class Period"), are encouraged to contact the Firm in advance of the April 14, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here, or call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.
No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
USANA designs, manufactures, and sells nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. On February 7, 2017, USANA announced that it will be initiating an internal investigation of its Chinese subsidiary, BabyCare Ltd. ("BabyCare").
The Company's investigation specifically concerns "compliance with the Foreign Corrupt Practices Act," as well as "BabyCare's expense reimbursement policies." When this information was announced to the investing public, the value of USANA dropped, causing investors harm.
Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders' rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact:
Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
SOURCE: Khang & Khang LLP
ReleaseID: 458045
